Log in

NYSE:USNAUSANA Health Sciences Stock Price, Forecast & News

+0.23 (+0.28 %)
(As of 08/4/2020 04:00 PM ET)
Today's Range
Now: $81.41
50-Day Range
MA: $80.30
52-Week Range
Now: $81.41
Volume133,724 shs
Average Volume216,571 shs
Market Capitalization$1.71 billion
P/E Ratio16.12
Dividend YieldN/A
USANA Health Sciences, Inc. develops, manufactures, and sells science-based nutritional and personal care products primarily to reduce the risk of chronic degenerative disease. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers comprising targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and foods that include low-glycemic meal replacement shakes, snack bars, and other related products, which provide macro-nutrition. It also provides Sensé—beautiful science products, such as personal care products that support healthy skin and hair through topical nourishment, moisturization, and protection; Celavive, a skin care regimen for various skin care types and ethnicities; and other products for prenatal, infant, and young child age groups. In addition, the company offers materials and online tools to assist associates in building their businesses, as well as in marketing products. It offers its products directly in the Asia Pacific, the Americas, and Europe. USANA Health Sciences, Inc. was founded in 1992 and is headquartered in Salt Lake City, Utah.
Read More
USANA Health Sciences logo

Beat the Market (BTM) Rank

Analyst Opinion: 1.3Community Rank: 2.2Dividend Strength: 0.0Insider Behavior: 2.0Valuation: 1.9 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.47 out of 5 stars

Industry, Sector and Symbol

Industry Medicinals & botanicals
Sub-IndustryPersonal Products



Sales & Book Value

Annual Sales$1.06 billion
Cash Flow$5.73 per share
Book Value$16.25 per share


Net Income$100.53 million


Market Cap$1.71 billion
Next Earnings Date10/27/2020 (Estimated)
+0.23 (+0.28 %)
(As of 08/4/2020 04:00 PM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive USNA News and Ratings via Email

Sign-up to receive the latest news and ratings for USNA and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles

USANA Health Sciences (NYSE:USNA) Frequently Asked Questions

How has USANA Health Sciences' stock been impacted by COVID-19 (Coronavirus)?

USANA Health Sciences' stock was trading at $69.88 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, USNA stock has increased by 16.5% and is now trading at $81.41.
View which stocks have been most impacted by Coronavirus

Do Wall Street analysts recommend investors buy shares of USANA Health Sciences?

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for USANA Health Sciences in the last year. There are currently 1 hold rating and 1 buy rating for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for USANA Health Sciences

When is USANA Health Sciences' next earnings date?

USANA Health Sciences is scheduled to release its next quarterly earnings announcement on Tuesday, October 27th 2020.
View our earnings forecast for USANA Health Sciences

How were USANA Health Sciences' earnings last quarter?

USANA Health Sciences, Inc. (NYSE:USNA) posted its earnings results on Tuesday, July, 21st. The company reported $1.32 EPS for the quarter, beating the consensus estimate of $1.08 by $0.24. The firm earned $258.99 million during the quarter, compared to analyst estimates of $267.80 million. USANA Health Sciences had a return on equity of 32.87% and a net margin of 10.35%. During the same quarter in the previous year, the company earned $0.91 EPS.
View USANA Health Sciences' earnings history

How will USANA Health Sciences' stock buyback program work?

USANA Health Sciences declared that its Board of Directors has approved a share repurchase program on Wednesday, February 5th 2020, which permits the company to buyback $130,000,000.00 in shares, according to EventVestor. This buyback authorization permits the company to repurchase up to 9.1% of its shares through open market purchases. Shares buyback programs are typically an indication that the company's board believes its shares are undervalued.

What guidance has USANA Health Sciences issued on next quarter's earnings?

USANA Health Sciences issued an update on its FY 2020 After-Hours earnings guidance on Tuesday, July, 21st. The company provided earnings per share (EPS) guidance of 4.70-5.25 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $4.88. The company issued revenue guidance of $1.05-1.1 billion, compared to the consensus revenue estimate of $1.07 billion.

What price target have analysts set for USNA?

2 equities research analysts have issued twelve-month target prices for USANA Health Sciences' shares. Their forecasts range from $65.00 to $65.00. On average, they anticipate USANA Health Sciences' stock price to reach $65.00 in the next year. This suggests that the stock has a possible downside of 20.2%.
View analysts' price targets for USANA Health Sciences

Has USANA Health Sciences been receiving favorable news coverage?

News headlines about USNA stock have been trending somewhat negative this week, according to InfoTrie Sentiment. The research group scores the sentiment of news coverage by reviewing more than six thousand blog and news sources in real-time. The firm ranks coverage of companies on a scale of negative five to five, with scores closest to five being the most favorable. USANA Health Sciences earned a news sentiment score of -1.0 on InfoTrie's scale. They also assigned news stories about the company a news buzz of 5.0 out of 10, indicating that recent news coverage is somewhat likely to have an effect on the stock's share price in the next several days.
View the latest news about USANA Health Sciences

Are investors shorting USANA Health Sciences?

USANA Health Sciences saw a decrease in short interest in the month of July. As of July 15th, there was short interest totaling 1,230,000 shares, a decrease of 15.2% from the June 30th total of 1,450,000 shares. Based on an average daily trading volume, of 222,800 shares, the days-to-cover ratio is presently 5.5 days. Approximately 10.3% of the company's stock are short sold.
View USANA Health Sciences' Current Options Chain

Who are some of USANA Health Sciences' key competitors?

What other stocks do shareholders of USANA Health Sciences own?

Based on aggregate information from My MarketBeat watchlists, some companies that other USANA Health Sciences investors own include IBM (IBM), Gilead Sciences (GILD), AT&T (T), Allergan (AGN), AbbVie (ABBV), Amgen (AMGN), Intel (INTC), Intuitive Surgical (ISRG), NVIDIA (NVDA) and Tesla (TSLA).

Who are USANA Health Sciences' key executives?

USANA Health Sciences' management team includes the following people:
  • Dr. Myron W. Wentz, Founder & Chairman (Age 78)
  • Mr. Kevin G. Guest, CEO & Director (Age 56)
  • Mr. Jim Brown, Pres & COO (Age 50)
  • Mr. G. Douglas Hekking, Chief Financial Officer (Age 49)
  • Mr. Walter Noot, Chief Information Officer (Age 53)

What is USANA Health Sciences' stock symbol?

USANA Health Sciences trades on the New York Stock Exchange (NYSE) under the ticker symbol "USNA."

Who are USANA Health Sciences' major shareholders?

USANA Health Sciences' stock is owned by many different institutional and retail investors. Top institutional shareholders include Robeco Institutional Asset Management B.V. (0.34%), Mackay Shields LLC (0.17%), MERIAN GLOBAL INVESTORS UK Ltd (0.15%), Empowered Funds LLC (0.15%), New York State Teachers Retirement System (0.09%) and Vident Investment Advisory LLC (0.08%). Company insiders that own USANA Health Sciences stock include Brent Neidig, Daniel A Macuga, Feng Peng, Frederic J Winssinger, G Doug Iiekking, Gilbert A Fuller, Global Ltd Gull, Jim Brown, Joshua Foukas, Kevin Guest, Myron W Wentz, Robert A Sinnott, Robert Auciaux, Timothy E Wood and Walter Noot.
View institutional ownership trends for USANA Health Sciences

Which institutional investors are selling USANA Health Sciences stock?

USNA stock was sold by a variety of institutional investors in the last quarter, including UBS Group AG, Robeco Institutional Asset Management B.V., First Quadrant L P CA, Mackay Shields LLC, MERIAN GLOBAL INVESTORS UK Ltd, SG Americas Securities LLC, First Trust Advisors LP, and Vident Investment Advisory LLC. Company insiders that have sold USANA Health Sciences company stock in the last year include Brent Neidig, Daniel A Macuga, Feng Peng, Frederic J Winssinger, G Doug Iiekking, Gilbert A Fuller, Jim Brown, Joshua Foukas, Kevin Guest, Myron W Wentz, Robert Auciaux, Timothy E Wood, and Walter Noot.
View insider buying and selling activity for USANA Health Sciences

Which institutional investors are buying USANA Health Sciences stock?

USNA stock was purchased by a variety of institutional investors in the last quarter, including Empowered Funds LLC, New York State Teachers Retirement System, Campbell & CO Investment Adviser LLC, Louisiana State Employees Retirement System, Arizona State Retirement System, Everence Capital Management Inc., Comerica Bank, and Pacer Advisors Inc.. Company insiders that have bought USANA Health Sciences stock in the last two years include Global Ltd Gull, and Myron W Wentz.
View insider buying and selling activity for USANA Health Sciences

How do I buy shares of USANA Health Sciences?

Shares of USNA can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is USANA Health Sciences' stock price today?

One share of USNA stock can currently be purchased for approximately $81.41.

How big of a company is USANA Health Sciences?

USANA Health Sciences has a market capitalization of $1.71 billion and generates $1.06 billion in revenue each year. The company earns $100.53 million in net income (profit) each year or $4.41 on an earnings per share basis. USANA Health Sciences employs 1,909 workers across the globe.

What is USANA Health Sciences' official website?

The official website for USANA Health Sciences is www.usana.com.

How can I contact USANA Health Sciences?

USANA Health Sciences' mailing address is 3838 West Parkway Blvd, Salt Lake City UT, 84120. The company can be reached via phone at 801-954-7100 or via email at [email protected]

This page was last updated on 8/5/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.